Global Gabapentin Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

SKU ID : GIR-GIR1805090006 11564979

Publishing Date : 09-May-2018

No. of pages : 104

PRICE
3480
4680


  • Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.

    Scope of the Report:
    This report focuses on the Gabapentin in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
    Market Segment by Manufacturers, this report covers
    Pfizer
    Depomed
    TEVA
    Mylan
    Arbor Pharma
    Novartis
    Apotex
    Sun Pharmaceutical
    Aurobindo Pharma
    Intas
    Amneal
    Marksans Pharma
    Glenmark
    Alkem
    Jiangsu Enhua
    Jiangsu Hengrui
    Sailike

    Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Capsule
    Tablet

    Market Segment by Applications, can be divided into
    Epilepsy
    Neuropathic Pain
    Restless Legs Syndrome
    Others

    There are 15 Chapters to deeply display the global Gabapentin market.

    Chapter 1, to describe Gabapentin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

    Chapter 2, to analyze the top manufacturers of Gabapentin, with sales, revenue, and price of Gabapentin, in 2016 and 2017;

    Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

    Chapter 4, to show the global market by regions, with sales, revenue and market share of Gabapentin, for each region, from 2013 to 2018;

    Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

    Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

    Chapter 12, Gabapentin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

    Chapter 13, 14 and 15, to describe Gabapentin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports